Get the Stockscreener App
227.01
0.55%
1.25
Pre-market:
229.96
2.95
+1.30%
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $227.01, with a volume of 579.90K.
It is up +0.55% in the last 24 hours and down -0.22% over the past month.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$225.76
Open:
$226.39
24h Volume:
579.90K
Relative Volume:
1.04
Market Cap:
$19.06B
Revenue:
$12.49B
Net Income/Loss:
$449.50M
P/E Ratio:
30.35
EPS:
7.48
Net Cash Flow:
$852.30M
1W Performance:
+3.03%
1M Performance:
-0.22%
6M Performance:
+8.51%
1Y Performance:
+12.58%
1-Day Range:
$225.98
$229.13
1-Week Range:
$213.91
$229.13
52-Week Range:
$191.97
$238.47
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience - Quantisnow
LabCorp slashes workforce in Melbourne after $237.5 million acquisition - The Business Journals
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health - Yahoo Finance
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 - PR Newswire
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - BioSpace
Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health - XM
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - PR Newswire
Indo-Asian News Service - IANS India Pvt Ltd
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes - MSN
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)? - Simply Wall St
Pharmaceutical CDMO Market Size to Achieve USD 345.6 Billion by 2033 - GlobeNewswire Inc.
Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability - Seeking Alpha
Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Ballad Health to sell non-hospital lab services to Labcorp - Yahoo Finance
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Investors in Labcorp Holdings (NYSE:LH) have seen favorable returns of 59% over the past five years - Yahoo Finance
Baird boosts Laboratory Corporation of America stock target, retains Outperform - Investing.com India
Baird boosts Laboratory Corporation of America stock target, retains Outperform - Investing.com
Labcorp to Speak at the Baird 2024 Global Healthcare Conference - PR Newswire
Labcorp to Speak at the Baird 2024 Global Healthcare Conference - StockTitan
Labcorp Exceeds Q2 Expectations And Updates Sales Forecast - Finimize
Labcorp : and Community Clinical Oncology Research Network Collaborate to Assess Social and Economic Impacts of Disparities in Cancer Care - Marketscreener.com
Should You Invest in Labcorp Holdings (LH)? - MSN
Labcorp considering ramping up mpox testing capacity: report - MSN
Labcorp Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Are Wall Street Analysts Bullish on Labcorp Holdings Stock? - Inkl
Are Wall Street Analysts Bullish On Labcorp Holdings Stock? - Barchart
Should You Invest in Labcorp Holdings (LH)? - Yahoo Finance UK
Should You Invest in Labcorp Holdings (LH)? - Insider Monkey
Should You Invest in Labcorp Holdings (LH)? - Yahoo Finance
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain - Benzinga
Diagnostics firm Labcorp weighs ramping up mpox testing capacity - Reuters
Labcorp Says It Has Capacity To Process About 25,000 Mpox Tests Per Month - XM
Investors in Labcorp Holdings (NYSE:LH) have seen notable returns of 65% over the past five years - Simply Wall St
Should You Hold Labcorp (LH) Stock in Your Portfolio Now? - Yahoo Finance
Should You Hold Labcorp (LH) Stock in Your Portfolio Now? - Zacks Investment Research
Insider Sale: EVP, Chief Legal Officer Sandra D van der Vaart Se - GuruFocus.com
Insider Sale: EVP, Chief Legal Officer Sandra D van der Vaart Sells 2,000 Shares of Labcorp ... - Yahoo Finance
Insider Sale: EVP, Chief Legal Officer Sandra D van der Vaart Sells 2,000 Shares of Labcorp ... By GuruFocus - Investing.com Canada
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer - Yahoo Finance
Labcorp CFO Glenn Eisenberg sells shares worth over $3.3 million - Investing.com
Insider Sale: CFO Glenn Eisenberg Sells 15,000 Shares of Labcorp Holdings Inc (LH) By GuruFocus - Investing.com Canada
Labcorp CFO Glenn Eisenberg sells shares worth over $3.3 million By Investing.com - Investing.com Canada
Insider Sale: CFO Glenn Eisenberg Sells 15,000 Shares of Labcorp Holdings Inc (LH) - GuruFocus.com
Labcorp Holdings Inc. stock rises Thursday, still underperforms market - MarketWatch
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024 - GlobeNewswire Inc.
Labcorp Announces 2024 First Quarter Results - Longview News-Journal
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp (LH) Gains From New Collaborations Amid FX Issues - Yahoo Finance
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):